Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
Clinical trial NCT00130156 · COMPLETED
Trial details
- NCT number
- NCT00130156
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-09-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.